相关实验视频
Updated: Jan 12, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.1K
后COVID-19 相关的无症状沙丘病与高热血症和功能障碍:一个病例报告和文献综述
Mrudula Thiriveedi1, Hersh Patel2, Caitlin Curran2
1Department of Internal Medicine, Decatur Morgan Hospital, Decatur, AL, USA.
The American journal of case reports
|November 1, 2025
概括
这一案例突出显示了COVID-19感染后的一种罕见的无症状沙尔科发病例. 关键的诊断线索包括高血症和高水平的1,25-二氧维生素D,即使没有典型的症状.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 沙丘病是一个多系统的细粒体性疾病,原因不明,往往表现为模糊的症状,缺乏确定的诊断测试.
- 诊断在缺乏标志性特征的非典型病例中具有挑战性,例如双边状淋巴结核病或皮肤病变.
- 新出现的证据表明,2019年新冠病毒病 (COVID-19) 后的免疫失调可能会引发沙尔科毒症.
研究的目的:
- 报告一个在COVID-19感染后出现的无症状沙尔科毒症的独特病例.
- 为了强调高血症和非典型的肉类瘤中1,25-二氧维生素D水平升高的诊断重要性.
- 为 COVID-19 和 Sarcoidosis 之间潜在联系的新兴文献做出贡献.
主要方法:
- 一个60岁的女性患有高血压和最近的COVID-19病例报告.
- 调查持续性高血症,功能衰竭和贫血.
- 诊断工作包括生物化学测试,成像和淋巴结活检,揭示非病变性颗粒瘤.
主要成果:
- 患者出现了COVID-19后的高血症,功能衰竭和贫血,持续的无性.
- 生物化学测试显示抑制了副甲状腺激素 (PTH) 和增加了1,25-二氧维生素D.
- 淋巴结活检证实了肉类发病症;用普雷尼松治疗改善了生物化学和放射性发现.
结论:
- 在没有经典特征的情况下, Sarcoidosis 诊断可能是具有挑战性的,这强调了高血症和1,25-二氧维生素 D 的重要性.
- 据我们所知,这种病例代表了在COVID-19后的环境中首次报告无症状的 Sarcoidosis.
- 需要进一步的研究来确定COVID-19和沙尔科毒症之间的因果关系,因为这是单个患者的观察.
更多相关视频
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
540
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
540
01:26Nephrotic Syndrome II : Assessment and Medical Management
189
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
189
01:24Nephrotic Syndrome I : Introduction
486
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
486
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
439
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
439
01:24Nephrotic Syndrome III : Nursing Management
276
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
276
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
361
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
361